Literature DB >> 31100732

The effect of preoperative embolization and flow dynamics on resection of brain arteriovenous malformations.

Grace F Donzelli1, Jeffrey Nelson2, David McCoy3, Charles E McCulloch4, Steven W Hetts3, Matthew R Amans3, Christopher F Dowd3, Van V Halbach3, Randall T Higashida3, Michael T Lawton5, Helen Kim2, Daniel L Cooke3.   

Abstract

OBJECTIVEPreoperative embolization of brain arteriovenous malformations (AVMs) is performed to facilitate resection, although its impact on surgical performance has not been clearly defined. The authors tested for associations between embolization and surgical performance metrics.METHODSThe authors analyzed AVM cases resected by one neurosurgeon from 2006 to 2017. They tested whether cases with and without embolization differed from one another with respect to patient and AVM characteristics using t-tests for continuous variables and Fisher's exact tests for categorical variables. They used simple and multivariable regression models to test whether surgical outcomes (blood loss, resection time, surgical clip usage, and modified Rankin Scale [mRS] score) were associated with embolization. Additional regression analyses integrated the peak arterial afferent contrast normalized for the size of the region of interest (Cmax/ROI) into models as an additional predictor.RESULTSThe authors included 319 patients, of whom 151 (47%) had preoperative embolization. Embolized AVMs tended to be larger (38% with diameter > 3 cm vs 19%, p = 0.001), less likely to have hemorrhaged (48% vs 63%, p = 0.013), or be diffuse (19% vs 29%, p = 0.045). Embolized AVMs were more likely to have both superficial and deep venous drainage and less likely to have exclusively deep drainage (32% vs 17% and 12% vs 23%, respectively; p = 0.002). In multivariable analysis, embolization was not a significant predictor of blood loss or mRS score changes, but did predict longer operating times (+29 minutes, 95% CI 2-56 minutes; p = 0.034) and increased clip usage (OR 2.61, 95% CI 1.45-4.71; p = 0.001). Cmax/ROI was not a significant predictor, although cases with large Cmax/ROI tended to have longer procedure times (+25 minutes per doubling of Cmax/ROI, 95% CI 0-50 minutes; p = 0.051).CONCLUSIONSIn this series, preoperative embolization was associated with longer median resection times and had no association with intraoperative blood loss or mRS score changes.

Entities:  

Keywords:  AVM = arteriovenous malformation; Cmax = peak contrast density of the primary feeding artery; Cmax/ROI = Cmax normalized for the size of the ROI (i.e., the diameter of the artery); EVOH = ethylene vinyl alcohol copolymer; NBCA = N-butyl 2-cyanoacrylate; PI = proportional increase; PVA = polyvinyl alcohol; ROI = region of interest; cerebrovascular procedures; digital subtraction angiography; embolization; intracranial arteriovenous malformations; mRS = modified Rankin Scale; vascular disorders

Year:  2019        PMID: 31100732      PMCID: PMC6858934          DOI: 10.3171/2019.2.JNS182743

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  31 in total

1.  AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association.

Authors:  C S Ogilvy; P E Stieg; I Awad; R D Brown; D Kondziolka; R Rosenwasser; W L Young; G Hademenos
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

Review 2.  Treatment of brain arteriovenous malformations: a systematic review and meta-analysis.

Authors:  Janneke van Beijnum; H Bart van der Worp; Dennis R Buis; Rustam Al-Shahi Salman; L Jaap Kappelle; Gabriël J E Rinkel; Jan Willem Berkelbach van der Sprenkel; W Peter Vandertop; Ale Algra; Catharina J M Klijn
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

3.  Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases.

Authors:  F Viñuela; J E Dion; G Duckwiler; N A Martin; P Lylyk; A Fox; D Pelz; C G Drake; J J Girvin; G Debrun
Journal:  J Neurosurg       Date:  1991-12       Impact factor: 5.115

4.  Quantitative assessment of changes in cerebral arteriovenous malformation hemodynamics after embolization.

Authors:  Ali Alaraj; Sepideh Amin-Hanjani; Sophia F Shakur; Victor A Aletich; Alexander Ivanov; Andrew P Carlson; Gerald Oh; Fady T Charbel
Journal:  Stroke       Date:  2015-03-05       Impact factor: 7.914

5.  Preoperative embolization of intracranial arteriovenous malformations with Onyx.

Authors:  Werner Weber; Bernhard Kis; Ralf Siekmann; Paul Jans; Rudolf Laumer; Dietmar Kühne
Journal:  Neurosurgery       Date:  2007-08       Impact factor: 4.654

6.  Intracranial venous hemodynamics and rupture of cerebral aneurysm.

Authors:  Kwo-Whei Lee; Fong-Y Tsai; Wei-Liang Chen; Chi-Kuang Liu; Chen-Ling Kuo
Journal:  Neuroradiol J       Date:  2014-12-01

7.  Treatment of cerebral arteriovenous malformations with a combination of preoperative embolization and surgery.

Authors:  A Pasqualin; R Scienza; F Cioffi; G Barone; A Benati; A Beltramello; R Da Pian
Journal:  Neurosurgery       Date:  1991-09       Impact factor: 4.654

8.  Higher Flow Is Present in Unruptured Arteriovenous Malformations With Silent Intralesional Microhemorrhages.

Authors:  Xiaolin Chen; Daniel L Cooke; David Saloner; Jeffrey Nelson; Hua Su; Michael T Lawton; Christopher Hess; Tarik Tihan; Yuanli Zhao; Helen Kim
Journal:  Stroke       Date:  2017-08-30       Impact factor: 7.914

9.  The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations.

Authors:  J J Jafar; A J Davis; A Berenstein; I S Choi; M J Kupersmith
Journal:  J Neurosurg       Date:  1993-01       Impact factor: 5.115

10.  Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits.

Authors:  Robert M Starke; Ricardo J Komotar; Marc L Otten; David K Hahn; Laura E Fischer; Brian Y Hwang; Matthew C Garrett; Robert R Sciacca; Michael B Sisti; Robert A Solomon; Sean D Lavine; E Sander Connolly; Philip M Meyers
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

View more
  7 in total

Review 1.  Surgical management outcomes of intracranial arteriovenous malformations after preoperative embolization: a systematic review and meta-analysis.

Authors:  Marian T Park; Muhammed Amir Essibayi; Visish M Srinivasan; Joshua S Catapano; Christopher S Graffeo; Michael T Lawton
Journal:  Neurosurg Rev       Date:  2022-09-27       Impact factor: 2.800

2.  Intraoperative Monitoring Cerebral Blood Flow During the Treatment of Brain Arteriovenous Malformations in Hybrid Operating Room by Laser Speckle Contrast Imaging.

Authors:  Sicai Tao; Tingbao Zhang; Keyao Zhou; Xiaohu Liu; Yu Feng; Wenyuan Zhao; Jincao Chen
Journal:  Front Surg       Date:  2022-05-06

3.  Update Onyx embolization for plexiform arteriovenous malformation: Ante-grade drifting technique.

Authors:  Xianli Lv; Shikai Liang
Journal:  Neuroradiol J       Date:  2020-07-16

4.  Spetzler-Martin Grade III Arteriovenous Malformations: A Multicenter Propensity-Adjusted Analysis of the Effects of Preoperative Embolization.

Authors:  Joshua S Catapano; Fabio A Frisoli; Candice L Nguyen; D Andrew Wilkinson; Neil Majmundar; Tyler S Cole; Jacob F Baranoski; Alexander C Whiting; Helen Kim; Andrew F Ducruet; Felipe C Albuquerque; Daniel L Cooke; Robert F Spetzler; Michael T Lawton
Journal:  Neurosurgery       Date:  2021-04-15       Impact factor: 4.654

Review 5.  Risk factors for hemorrhage of brain arteriovenous malformation.

Authors:  Sonali S Shaligram; Ethan Winkler; Daniel Cooke; Hua Su
Journal:  CNS Neurosci Ther       Date:  2019-07-29       Impact factor: 5.243

Review 6.  Preoperative embolisation of brain arteriovenous malformations: a systematic review and meta-analysis.

Authors:  Conor Brosnan; Michael Amoo; Mohsen Javadpour
Journal:  Neurosurg Rev       Date:  2022-03-09       Impact factor: 2.800

Review 7.  Review of treatment and therapeutic targets in brain arteriovenous malformation.

Authors:  Peipei Pan; Shantel Weinsheimer; Daniel Cooke; Ethan Winkler; Adib Abla; Helen Kim; Hua Su
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-23       Impact factor: 6.960

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.